The effect of Boron supplement on severity and duration of colic pain and the time of expulsion of urinary stone after Extracorporeal Shock Wave Lithotripsy

The effect of Boron supplement on severity and duration of colic pain and the time of expulsion of urinary stone after Extracorporeal Shock Wave Lithotripsy compared to Tamsulosin

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191026045244N3

Enrollment

160

Registered

2022-04-11

Start date

2018-04-05

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone. Calculus of kidney

Interventions

Intervention 1: Intervention group: Boron supplement capsule containing 88.5 mg sodium tetraborate decahydrate (Sigma, St. Louis, USA), i.e. (containing 10 mg Boron), and 221.5 mg lactose powder (as

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: kidney stone patients referred to urinary stone Extracorporeal Shock Wave Lithotripsy of Labbafi nejad clinic

Exclusion criteria

Exclusion criteria: Urinary Tract Infection Chronic Kidney Disease Urinary Tract Surgery history (PCNL or open stone) contraindications to extracorporeal shockwave lithotripsy (ESWL) include: Acute urinary tract infection or urosepsis, Uncorrected bleeding disorders or coagulopathies, Pregnancy. History of Estrogen-Dependent Cancer (Breast, Endometrial and Ovarian) pregnancy or lactation

Design outcomes

Primary

Measure	Time frame
Stone size. Timepoint: Before ESWL and 14 days after ESWL. Method of measurement: The size of the stone in millimeters reported in the patient's ultrasound.;Pain of expulsion. Timepoint: 14 days after ESWL. Method of measurement: Visual Analogue Scale.;Time of expulsion. Timepoint: 14 days after ESWL. Method of measurement: Questionnaire.;Auxillary treatment after ESWL. Timepoint: 14 days after ESWL. Method of measurement: Questionnaire.;Drug complications. Timepoint: 14 days after ESWL. Method of measurement: Questionnaire.	—

Measure

Time frame

Stone size. Timepoint: Before ESWL and 14 days after ESWL. Method of measurement: The size of the stone in millimeters reported in the patient's ultrasound.;Pain of expulsion. Timepoint: 14 days after ESWL. Method of measurement: Visual Analogue Scale.;Time of expulsion. Timepoint: 14 days after ESWL. Method of measurement: Questionnaire.;Auxillary treatment after ESWL. Timepoint: 14 days after ESWL. Method of measurement: Questionnaire.;Drug complications. Timepoint: 14 days after ESWL. Method of measurement: Questionnaire.

—

Secondary

Measure	Time frame
Number of pain medicines used. Timepoint: 14 days after ESWL. Method of measurement: questionnaire.;Serum creatinine. Timepoint: Before ESWL, 14 days after ESWL. Method of measurement: Calorimetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Taheri

Shahid Beheshti University of Medical Sciences

taheri233@yahoo.com+980212256722

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026